Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Covista Inc.DV · Entity 3964 | Director | November 10, 2016 | November 14, 2016 |
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Director | March 31, 2025 | April 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Covista Inc.
Report date November 10, 2016 · Filed November 14, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,057 |
Reported balance
After 2016-11-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2016-11-10 · Grant · Acquired 3,640 · Balance 15,057 F1: The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date. |
Filing footnotes · ownership attribution and instrument terms
F1: The common stock is a restricted stock unit which represents a right to receive one share of common stock for each restricted stock unit. Stock units vest 100% on the one year anniversary of the transaction date.
ZIMMER BIOMET HOLDINGS, INC.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $112.51 | Direct | 21,937.582 |
Reported balance
After 2025-03-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-03-31 · Grant · Acquired 533.286 · Balance 21,937.582 F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4: Includes 45.338 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
F2: The Conversion or Exercise Price of Derivative Security is 1-for-1.
F3: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.
F4: Includes 45.338 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ABBOTT LABORATORIES
Report date April 30, 2004 · Filed May 04, 2004
Section 16 reporting ended · disclosed 2004-05-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 240,618 |
Reported balance
After 2004-04-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2004-04-30 · Tax withholding · Disposed 3,506 · Balance 240,618 |
| Common SharesSEC Table I · non-derivative | Direct | 230,075 |
Reported balance
After 2004-04-30 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2004-04-30 · Tax withholding · Disposed 10,543 · Balance 230,075 |
| Common SharesSEC Table I · non-derivative | Direct | 222,484 |
Reported balance
After 2004-04-30 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2004-04-30 · Tax withholding · Disposed 7,591 · Balance 222,484 F1: These are holdings as of Mr. Begley's last day as Abbott Laboratories' Senior Vice President, Hospital Products, as a result of the April 30, 2004 spin-off of Hospira, Inc. from Abbott Laboratories. Mr. Begley is Chief Executive Officer of Hospira, Inc. |
| Common SharesSEC Table I · non-derivative | Indirectprofit sharing trust | 14,009 |
Reported balance
Holding disclosure · report date 2004-04-30 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 14,009 F1: These are holdings as of Mr. Begley's last day as Abbott Laboratories' Senior Vice President, Hospital Products, as a result of the April 30, 2004 spin-off of Hospira, Inc. from Abbott Laboratories. Mr. Begley is Chief Executive Officer of Hospira, Inc. F2: Balance in the Abbott Laboratories Stock Retirement Trust as of April 30, 2004. |
Filing footnotes · ownership attribution and instrument terms
F1: These are holdings as of Mr. Begley's last day as Abbott Laboratories' Senior Vice President, Hospital Products, as a result of the April 30, 2004 spin-off of Hospira, Inc. from Abbott Laboratories. Mr. Begley is Chief Executive Officer of Hospira, Inc.
F2: Balance in the Abbott Laboratories Stock Retirement Trust as of April 30, 2004.
HANGER, INC.
Report date October 03, 2022 · Filed October 04, 2022
Section 16 reporting ended · disclosed 2022-10-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 1
1 source rowRow 1 · 2022-10-03 · Disposition to issuer · Disposed 76,414 · Balance 0 F1: Represents shares of issuer's common stock and restricted stock units relating to such common stock that were disposed of in connection with the merger of Hero Merger Sub, Inc. with and into issuer (the "Merger") pursuant to the Agreement and Plan of Merger, dated as of July 21, 2022, by and among issuer, Hero Parent, Inc. and Hero Merger Sub, Inc. (the "Merger Agreement"). At the effective time of the Merger, each issued and outstanding share of issuer's common stock (subject to certain exceptions described in the Merger Agreement) and each restricted stock unit were canceled and converted into the right to receive $18.75 in cash. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of issuer's common stock and restricted stock units relating to such common stock that were disposed of in connection with the merger of Hero Merger Sub, Inc. with and into issuer (the "Merger") pursuant to the Agreement and Plan of Merger, dated as of July 21, 2022, by and among issuer, Hero Parent, Inc. and Hero Merger Sub, Inc. (the "Merger Agreement"). At the effective time of the Merger, each issued and outstanding share of issuer's common stock (subject to certain exceptions described in the Merger Agreement) and each restricted stock unit were canceled and converted into the right to receive $18.75 in cash.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2025 Filed Apr 2, 2025 20:11 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 533.286 | $0.00 Strike: $112.51 | $0.00 |
DisclosureSEC source: 0001062993-25-006824 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,937.582 Underlying: Common Stock · 533.286 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 45.338 phantom stock units accrued on January 31, 2025 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 21:08 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 567.483 | $0.00 Strike: $105.73 | $0.00 |
DisclosureSEC source: 0001062993-25-000136 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,358.958 Underlying: Common Stock · 567.483 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 46.037 phantom stock units accrued on October 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:22 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 556.793 | $0.00 Strike: $107.76 | $0.00 |
DisclosureSEC source: 0001062993-24-017255 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,745.438 Underlying: Common Stock · 556.793 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 42.136 phantom stock units accrued on July 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:52 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 553.097 | $0.00 Strike: $108.48 | $0.00 |
DisclosureSEC source: 0001062993-24-013336 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,146.509 Underlying: Common Stock · 553.097 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 10, 2024 Filed May 14, 2024 20:54 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,068.991 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-010207 · form4.xml · derivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,683.928 Underlying: Common Stock · 1,068.991 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 10, 2024 Filed May 14, 2024 20:54 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 616.726 | $0.00 Strike: $121.61 | $0.00 |
DisclosureSEC source: 0001062993-24-010207 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,593.412 Underlying: Common Stock · 616.726 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 36.719 phantom stock units accrued on April 30, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 21:22 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 451.977 | $0.00 Strike: $132.75 | $0.00 |
DisclosureSEC source: 0001062993-24-007762 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,939.967 Underlying: Common Stock · 451.977 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 34.283 phantom stock units accrued on January 31, 2024 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 23:11 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 492.53 | $0.00 Strike: $121.82 | $0.00 |
DisclosureSEC source: 0001062993-24-000258 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,453.707 Underlying: Common Stock · 492.53 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 40.004 phantom stock units accrued on October 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 20:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 531.161 | $0.00 Strike: $112.96 | $0.00 |
DisclosureSEC source: 0001062993-23-018799 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,921.173 Underlying: Common Stock · 531.161 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 29.639 phantom stock units accrued on July 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| August 28, 2023 Filed Sep 29, 2023 20:05 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | PurchaseCommon Stock | 1,000 | $117.11 | $117,114.00 |
DisclosureSEC source: 0001062993-23-018607 · form4.xml · nonDerivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,540 Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 20:26 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 255.955 | $0.00 Strike: $146.51 | $0.00 |
DisclosureSEC source: 0001062993-23-014483 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,360.373 Underlying: Common Stock · 255.955 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:13 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 950.779 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-011209 · form4.xml · derivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,614.937 Underlying: Common Stock · 950.779 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:13 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $136.73 | $0.00 |
DisclosureSEC source: 0001062993-23-011209 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,104.418 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 28.223 phantom stock units accrued on April 28, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:14 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 291.806 | $0.00 Strike: $128.51 | $0.00 |
DisclosureSEC source: 0001062993-23-008489 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,576.195 Underlying: Common Stock · 291.806 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 30.335 phantom stock units accrued on January 31, 2023 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 21:11 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 295.346 | $0.00 Strike: $126.97 | $0.00 |
DisclosureSEC source: 0001062993-23-000259 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,254.054 Underlying: Common Stock · 295.346 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 33.829 phantom stock units accrued on October 31, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 17:18 UTC | HANGER, INC. HNGR · Entity 14115 | Disposition to issuerCommon Stock | 76,414 | $18.75 | $1,432,762.50 |
DisclosureSEC source: 0001567619-22-018176 · doc1.xml · nonDerivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · acquired: Represents shares of issuer's common stock and restricted stock units relating to such common stock that were disposed of in connection with the merger of Hero Merger Sub, Inc. with and into issuer (the "Merger") pursuant to the Agreement and Plan of Merger, dated as of July 21, 2022, by and among issuer, Hero Parent, Inc. and Hero Merger Sub, Inc. (the "Merger Agreement"). At the effective time of the Merger, each issued and outstanding share of issuer's common stock (subject to certain exceptions described in the Merger Agreement) and each restricted stock unit were canceled and converted into the right to receive $18.75 in cash. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 20:29 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 352.344 | $0.00 Strike: $106.43 | $0.00 |
DisclosureSEC source: 0001062993-22-020324 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,924.879 Underlying: Common Stock · 352.344 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 33.167 phantom stock units accrued on July 29, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:36 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 356.973 | $0.00 Strike: $105.05 | $0.00 |
DisclosureSEC source: 0001062993-22-015942 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,539.368 Underlying: Common Stock · 356.973 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 16:38 UTC | HANGER, INC. HNGR · Entity 14115 | GrantCommon Stock | 9,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012283 · doc1.xml · nonDerivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,414 F1 · shares: Consists of shares of restricted stock granted under the Company's 2022 Omnibus Incentive Plan (the "Plan"), which vest 100% on June 2, 2023, subject to certain provisions of the Plan. Read SEC document |
| May 13, 2022 Filed May 17, 2022 21:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,129.158 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-012800 · form4.xml · derivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,664.158 Underlying: Common Stock · 1,129.158 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Also reflects the adjustments that occurred as of March 1, 2022 in connection with the spinoff of ZimVie Inc. In connection with the spinoff, each then outstanding Restricted Stock Unit was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit. Read SEC document |
| May 13, 2022 Filed May 17, 2022 21:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $115.13 | $0.00 |
DisclosureSEC source: 0001062993-22-012800 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,182.395 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: These units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 27.313 phantom stock units accrued on April 29, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:15 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 291.082 | $0.00 Strike: $128.83 | $0.00 |
DisclosureSEC source: 0001062993-22-009408 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,655.082 Underlying: Common Stock · 291.082 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. (the "Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 27.747 phantom stock units accrued on January 31, 2022 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F5 · balance_after: Holdings reflect the adjustments that occurred as of March 1, 2022 in connection with the Company's spinoff of Zimvie Inc. In connection with the spinoff, each outstanding phantom stock unit was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 22:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 292.9 | $0.00 Strike: $128.03 | $0.00 |
DisclosureSEC source: 0001062993-22-000331 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,906.398 Underlying: Common Stock · 292.9 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 23.072 phantom stock units accrued on October 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:09 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 252.746 | $0.00 Strike: $148.37 | $0.00 |
DisclosureSEC source: 0001062993-21-009195 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,590.426 Underlying: Common Stock · 252.746 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 19.15 phantom stock units accrued on July 31, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:38 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 256.323 | $0.00 Strike: $160.93 | $0.00 |
DisclosureSEC source: 0001062993-21-006277 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,318.53 Underlying: Common Stock · 256.323 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 26, 2021 Filed May 27, 2021 16:58 UTC | HANGER, INC. HNGR · Entity 14115 | GrantCommon Stock | 5,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-011269 · doc1.xml · nonDerivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,503 F1 · shares: Consists of shares of restricted stock granted under the Company's 2019 Omnibus Incentive Plan (the "Plan"), which vest 100% on May 26, 2022, subject to certain provisions of the Plan. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 779.05 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-004821 · form4.xml · derivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,220.16 Underlying: Common Stock · 779.05 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $166.87 | $0.00 |
DisclosureSEC source: 0001062993-21-004821 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,062.207 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 16.724 phantom stock units accrued on April 30, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 16:40 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 192.937 | $0.00 Strike: $161.97 | $0.00 |
DisclosureSEC source: 0001062993-21-003331 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,545.483 Underlying: Common Stock · 192.937 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 18.864 phantom stock units accrued on January 29, 2021 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 204.422 | $0.00 Strike: $152.87 | $0.00 |
DisclosureSEC source: 0001062993-21-000105 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,333.682 Underlying: Common Stock · 204.422 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 21.94 phantom stock units accrued on October 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 230.185 | $0.00 Strike: $135.76 | $0.00 |
DisclosureSEC source: 0001062993-20-004772 · form4.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,107.32 Underlying: Common Stock · 230.185 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 20.533 phantom stock units accrued on July 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:48 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 263.981 | $0.00 Strike: $118.38 | $0.00 |
DisclosureSEC source: 0000911916-20-000156 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,856.602 Underlying: Common Stock · 263.981 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| May 20, 2020 Filed May 21, 2020 16:49 UTC | HANGER, INC. HNGR · Entity 14115 | GrantCommon Stock | 8,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-010929 · doc1.xml · nonDerivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,019 F1 · shares: Consists of shares of restricted stock granted under the Company's 2019 Omnibus Incentive Plan (the "Plan"), which vest 100% on May 20, 2021, subject to certain provisions of the Plan. Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,077.229 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000098 · edgar.xml · derivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,441.11 Underlying: Common Stock · 1,077.229 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 08, 2020 Filed May 12, 2020 20:30 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.68 | $0.00 |
DisclosureSEC source: 0000911916-20-000098 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,592.621 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 21.401 phantom stock units accrued on April 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 21:13 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 315.593 | $0.00 Strike: $99.02 | $0.00 |
DisclosureSEC source: 0000911916-20-000080 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,071.22 Underlying: Common Stock · 315.593 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 16.938 phantom stock units accrued on January 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:32 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 209.732 | $0.00 Strike: $149.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000002 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,738.689 Underlying: Common Stock · 209.732 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 18.321 phantom stock units accrued on October 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 20:33 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 202.013 | $0.00 Strike: $136.13 | $0.00 |
DisclosureSEC source: 0000911916-19-000168 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,510.636 Underlying: Common Stock · 202.013 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 17.865 phantom stock units accrued on July 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:18 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 236.397 | $0.00 Strike: $116.33 | $0.00 |
DisclosureSEC source: 0000911916-19-000148 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,290.758 Underlying: Common Stock · 236.397 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: This amount reflects the deduction of 98.551 units to correct an error in the reporting person's Forms 4 filed on April 2, 2019 and May 14, 2019, in which the number of phantom stock units received by the reporting person on March 31, 2019, and the total number of phantom stock units held by the reporting person following that date, were over-reported by 98.551 units. Read SEC document |
| May 23, 2019 Filed May 24, 2019 17:45 UTC | HANGER, INC. HNGR · Entity 14115 | GrantCommon Stock | 6,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-012142 · doc1.xml · nonDerivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,841 F1 · shares: Consists of shares of restricted stock granted under the Company's 2019 Omnibus Incentive Plan (the "Plan"), which vest 100% on May 23, 2020, subject to certain provisions of the Plan. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000107 · edgar.xml · derivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,363.881 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000107 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,152.912 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 18.351 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 23:00 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 314.695 | $0.00 Strike: $127.23 | $0.00 |
DisclosureSEC source: 0000911916-19-000096 · edgar.xml · derivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,634.561 Underlying: Common Stock · 314.695 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F4 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 23:00 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 98.551 | $0.00 Strike: $115.47 | $0.00 |
DisclosureSEC source: 0000911916-19-000096 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,319.866 Underlying: Common Stock · 98.551 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · shares: Represents phantom stock units credited to the reporting person under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors, as units earned but not credited for committee chair fees in 2018 and related units for dividend payments following the date the units were earned. F4 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.underlying_shares: Represents phantom stock units credited to the reporting person under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors, as units earned but not credited for committee chair fees in 2018 and related units for dividend payments following the date the units were earned. F5 · balance_after: Includes 19.794 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| February 06, 2019 Filed Feb 6, 2019 21:51 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | PurchaseCommon Stock | 2,040 | $117.19 | $239,069.44 |
DisclosureSEC source: 0000911916-19-000022 · edgar.xml · nonDerivative · entry 4 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,540 Read SEC document |
| February 06, 2019 Filed Feb 6, 2019 21:51 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | PurchaseCommon Stock | 200 | $117.18 | $23,436.46 |
DisclosureSEC source: 0000911916-19-000022 · edgar.xml · nonDerivative · entry 3 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Read SEC document |
| February 06, 2019 Filed Feb 6, 2019 21:51 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | PurchaseCommon Stock | 200 | $117.18 | $23,435.72 |
DisclosureSEC source: 0000911916-19-000022 · edgar.xml · nonDerivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 Read SEC document |
| February 06, 2019 Filed Feb 6, 2019 21:51 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | PurchaseCommon Stock | 100 | $117.17 | $11,717.11 |
DisclosureSEC source: 0000911916-19-000022 · edgar.xml · nonDerivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:15 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 229.668 | $0.00 Strike: $103.41 | $0.00 |
DisclosureSEC source: 0000911916-19-000001 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,201.521 Underlying: Common Stock · 229.668 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 18.343 phantom stock units accrued on October 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 19:43 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantPhantom Stock Units · Derivative | 181.783 | $0.00 Strike: $130.65 | $0.00 |
DisclosureSEC source: 0000911916-18-000175 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,953.51 Underlying: Common Stock · 181.783 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 16.292 phantom stock units accrued on July 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.